- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: H1 antihistamine, H2 antihistamine, leukotriene receptor antagonist
Total 344 results
-
Genentech, Inc.CompletedChronic Idiopathic UrticariaGermany, United Kingdom, United States, Switzerland, Australia, New Zealand, Poland, Singapore
-
Chongqing Medical UniversityRecruiting
-
Johanna Maria VermeulenNanjing University of Chinese Medicine; Mermaid Medicine®Completed
-
Bayside HealthCompletedAllergic RhinitisAustralia
-
University GhentResearch Foundation FlandersCompletedExercise | HistamineBelgium
-
Erasmus Medical CenterSanofiActive, not recruitingMetastatic Prostate Cancer | Circulating Tumor CellNetherlands
-
Gachon University Gil Medical CenterHallym University Medical Center; Hallym University Kangnam Sacred Heart Hospital and other collaboratorsRecruitingAllergic RhinitisKorea, Republic of
-
University of CincinnatiUnknownIrritable Bowel Syndrome | Dermatographism | Post-prandial Diarrhea
-
Consorci Sanitari de TerrassaInstitut Català de la Salut; Fundacio d'Investigacio en Atencio Primaria Jordi...RecruitingCOVID19 | ACE Inhibitors | ARB | Influenza Vaccination | Amantadine | Antihistamine AllergySpain
-
Goldman, Butterwick, Fitzpatrick and GroffDUSA Pharmaceuticals, Inc.Completed
-
Hamilton Health Sciences CorporationMcMaster University; AllerGen NCE Inc.Completed
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Spontaneous UrticariaChina, France, Spain, Argentina, Germany, Japan, United States, Canada, Hungary, Russian Federation, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedCold UrticariaUnited States, Argentina, Canada, Germany, Japan
-
Eisai Co., Ltd.Active, not recruiting
-
National Institute on Deafness and Other Communication...Completed
-
University of OregonRecruitingPostexercise HypotensionUnited States
-
Consorci Sanitari de TerrassaInstitut Català de la SalutRecruiting
-
Vanderbilt UniversityWithdrawnEndolymphatic Hydrops | Eustachian Tube DysfunctionUnited States
-
Chulalongkorn UniversityActive, not recruiting
-
Merck Sharp & Dohme LLCNot yet recruitingNon-small Cell Lung Cancer (NSCLC)
-
China Medical University HospitalCompleted
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
King Abdullah International Medical Research CenterRecruitingModerate Covid19Saudi Arabia
-
Merck Sharp & Dohme LLCRecruitingEsophageal Squamous Cell CarcinomaJapan, Korea, Republic of, China, Taiwan, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
-
Khon Kaen UniversityUnknownInflammation | PterygiumThailand
-
Stony Brook UniversityRecruiting
-
Children's Hospital of Fudan UniversityCompleted
-
Genentech, Inc.Completed
-
GlaxoSmithKlineTerminated
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
Ain Shams UniversityNasr City Insurance HospitalCompleted
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Mayo ClinicTerminated
-
Arrowhead PharmaceuticalsTerminatedHepatitis BKorea, Republic of, Germany, China
-
Guangzhou Institute of Respiratory DiseaseCompleted
-
Noha MansourNot yet recruitingBreast Cancer | Filgrastim Adverse Reaction
-
Tatyasaheb Kore Dental CollegeCompletedChronic PeriodontitisIndia
-
Emory UniversityCURE Drug Repurposing Collaboratory (CDRC)Recruiting
-
Wim DeraveUniversity of Copenhagen; Research Foundation FlandersCompleted
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Argentina, Poland, Canada, Australia, Belgium, Brazil, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Turkey, Ukraine, United Kingdom
-
Ultragenyx Pharmaceutical IncTerminatedGlycogen Storage Disease Type IIIUnited States, Spain, Italy
-
UCB S.A. - Pharma SectorCompleted
-
Otsuka Pharmaceutical Co., Ltd.CompletedHealthyKorea, Republic of
-
Aalborg UniversityCompleted
-
University of Sao Paulo General HospitalInCor Heart InstituteCompletedCoronary Artery Disease | Drug Interaction Potentiation
-
Indira Gandhi Medical College, ShimlaCompleted
-
University of SaskatchewanCompleted